Active, Not Recruiting
Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)
NCT06390839
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States